Clinical Trial Update: Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease

View source ↗

Summary

A postmarketing surveillance study of Atrovent for chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Atrovent (ipratropium bromide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED